PET/CT and PET/MR in Melanoma and Sarcoma

lt;p>

Amir H. Khandani is a tenured Associate Professor of Radiology and Division Chief of Molecular Imaging and Therapeutics (Mit) in the Department of Radiology at the at the University of North Carolina School of Medicine, Chapel Hill.  He received his medical training (MD) at the University of Cologne in Germany. He also completed his doctoral thesis at the Department of Nuclear Medicine at the University of Cologne and hold the German academic title "Dr. med.". He completed his internship at Elisabeth Hospital/West German Cancer Center in Recklinghausen and received his nuclear medicine residency training at the University Hospitals in Cologne and Erlangen. He is board certified by the American Board of Nuclear Medicine (ABNM) as well as German Board of Nuclear Medicine.

What is Positron Emission Tomography?.- Patient Preparation for FDG PET with an Emphasis on Soft Tissue Sarcoma and Melanoma: What Matters (and What Doesn't).- PET/CT and PET/MR in Soft Tissue Sarcoma and Melanoma Patients: What to Image and How to Image It.- Systematic Approach to Evaluation of Melanoma and Sarcoma with PET.- Review of PET/CT Images in Melanoma and Sarcoma: False-Positives, False-Negatives and Pitfalls.- PET beyond pictures.- The Role of PET/CT in Melanoma Patients: A Surgeon's Perspective.- PET in Sarcoma - Surgeons Point of View.- FDG PET in the Diagnosis and Management of Pediatric and Adolescent Sarcomas.- Beyond FDG: Novel Radiotracers for PET Imaging of Melanoma and Sarcoma.- Future Directions of PET and Molecular Imaging and Therapy with an Emphasis on Melanoma and Sarcoma.